What is the PALM (Pcrit, Arousal threshold, Loop gain, Muscle responsiveness) critical classification of obstructive sleep apnea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PALM Classification of Obstructive Sleep Apnea

The PALM classification represents four key physiological endotypes that drive OSA pathogenesis: Pcrit (pharyngeal critical closing pressure/upper airway collapsibility), Arousal threshold, Loop gain (ventilatory control stability), and Muscle responsiveness (upper airway dilator muscle function). 1

The Four PALM Components

P - Pcrit (Pharyngeal Critical Closing Pressure)

  • Measures anatomical collapsibility of the upper airway
  • Represents the pressure at which the pharynx passively collapses during sleep
  • More positive Pcrit values indicate greater collapsibility
  • In OSA patients, median Pcrit is 0.3 cm H₂O versus -6.2 cm H₂O in controls
  • However, 19% of OSA patients have relatively non-collapsible airways (Pcrit -2 to -5 cm H₂O), similar to controls 1

A - Arousal Threshold

  • Reflects how easily a patient awakens from sleep in response to respiratory stimuli
  • 37% of OSA patients have a low arousal threshold, meaning they wake too easily before compensatory mechanisms can prevent apnea 1
  • Low arousal threshold prevents upper airway muscles from adequately responding to obstruction

L - Loop Gain

  • Quantifies ventilatory control system stability
  • High loop gain indicates unstable breathing control with exaggerated ventilatory responses
  • 36% of OSA patients have high loop gain 1
  • In patients with non-collapsible airways (Pcrit -2 to -5 cm H₂O), loop gain is nearly twice as high (-5.9 vs -3.2), suggesting ventilatory instability drives their OSA 1

M - Muscle Responsiveness

  • Measures the ability of upper airway dilator muscles (particularly genioglossus) to respond to obstruction during sleep
  • 36% of OSA patients have minimal genioglossus muscle responsiveness 1
  • Poor muscle compensation allows airway collapse despite neural drive

Clinical Significance

These traits vary substantially among patients, confirming OSA is heterogeneous rather than purely anatomical. 1 The research demonstrates:

  • 28% of patients have multiple non-anatomic abnormalities 1
  • Non-anatomic features play an important role in 56% of OSA patients based on a three-point weighting scale 1
  • This framework enables phenotype-based individualized treatment rather than one-size-fits-all CPAP 2, 3

Measurement Approaches

PALM traits can be assessed through:

  • CPAP pressure titration during sleep studies
  • Esophageal pressure monitoring
  • Advanced PSG signal analysis 2

The 2025 Chinese guidelines recommend considering endotyping using these four physiological traits to guide individualized treatment selection 2, though standardized clinical implementation remains evolving.

Treatment Implications

Different PALM profiles predict response to specific therapies:

  • High loop gain → carbonic anhydrase inhibitors (acetazolamide, sultiame) 4
  • Low arousal threshold → selected sedating agents 4
  • Poor muscle responsiveness → noradrenergic-antimuscarinic combinations (AD109) 4
  • High Pcrit/anatomical → CPAP, oral appliances, surgery 3

This endotypic framework represents the shift from AHI-based diagnosis to mechanism-based precision treatment of OSA. 1, 5

References

Research

Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

American journal of respiratory and critical care medicine, 2013

Research

[Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025)].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2026

Research

The upper airway in obstructive sleep apnoea: state of the art.

European respiratory review : an official journal of the European Respiratory Society, 2026

Related Questions

What is the recommended medical therapy for obstructive sleep apnea in a patient with a low arousal threshold?
For a patient with severe obstructive sleep apnea (AHI 38.6, 214 obstructive events, nadir SaO2 65%) who is reluctant to use positive airway pressure therapy, what alternative management strategies should be pursued, considering her neuropathic pain, nocturnal leg cramps, and dry mouth?
As a 30-year-old non‑overweight male without snoring but with persistent fatigue and a past episode of waking gasping for air, should I be concerned about obstructive sleep apnea and possible organ damage, and is an at‑home sleep test appropriate?
In a 74-year-old patient with obstructive sleep apnea who refuses CPAP after multiple failed attempts, is it appropriate to try temazepam for insomnia?
In a 46-year-old woman with breast cancer who started leuprolide acetate (Lupron) and now has persistent heavy snoring, hot flashes, and fragmented sleep, how does hormone suppression from the GnRH agonist contribute to obstructive sleep apnea?
What Echinococcus species and genotypes are responsible for human cystic echinococcosis?
What are the possible causes of left gluteal muscle pain and what is the appropriate next step in management?
What are the indications, dosing regimens, and advantages of isosorbide mononitrate compared with isosorbide dinitrate for chronic angina and heart failure management?
What is the worldwide distribution and areas of highest prevalence of Echinococcus granulosus sensu lato?
How should cystic echinococcosis be diagnosed and managed in patients who have lived in or traveled to western China, central Asia, the Middle East, the Mediterranean region, eastern Africa, or parts of South America and present with hepatic, pulmonary, or other organ cystic lesions?
What is the recommended limit of digital screen exposure for a 7‑month‑old infant?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.